Adrenocortical carcinoma – Life with Disease

Go back

Adrenocortical carcinoma is a rare and aggressive cancer that develops in the outer layer of the adrenal glands. These small, triangle-shaped glands sit on top of the kidneys and produce hormones that help control blood pressure, metabolism, and the body’s response to stress. When cancer forms in this area, it can disrupt hormone production and grow rapidly, often spreading to other parts of the body. Understanding what to expect and how to prepare for the journey ahead can help patients and families navigate this challenging diagnosis with greater confidence.

Understanding the Outlook for Adrenocortical Carcinoma

Receiving a diagnosis of adrenocortical carcinoma can feel overwhelming, especially when learning about what the future may hold. This cancer is known for being aggressive, meaning it can grow and spread quickly. The prognosis, or expected outcome, depends heavily on how advanced the cancer is when it’s discovered. Healthcare providers use staging systems to describe how far the cancer has spread, and this information plays a crucial role in planning treatment and understanding what lies ahead.[1]

For patients diagnosed at an early stage, when the tumor is still confined to the adrenal gland and is smaller in size, the chances for long-term survival are significantly better. Research shows that five-year survival rates can be as high as 82% for stage I disease. However, the picture changes considerably when the cancer has spread beyond the adrenal gland. For stage IV disease, which means the cancer has reached distant organs such as the lungs, liver, or bones, the five-year survival rate drops to approximately 13%.[8]

It’s important to understand that around 70% of patients are diagnosed with stage III or IV disease, meaning the cancer has already advanced by the time it’s found. This happens because adrenocortical carcinoma often doesn’t cause noticeable symptoms in its early stages, particularly when tumors are nonfunctioning—meaning they don’t produce excess hormones that would trigger warning signs. Some patients only discover they have this cancer incidentally, during imaging tests performed for completely unrelated health concerns.[1][12]

⚠️ Important
Statistics about survival rates are based on large groups of patients and represent averages. Every person’s situation is unique, and many factors influence individual outcomes, including age, overall health, how well the cancer responds to treatment, and access to specialized care. Some patients live much longer than average predictions suggest, especially when their care is managed by experienced teams at specialized centers.

One of the most challenging aspects of adrenocortical carcinoma is its tendency to return after treatment. Even when surgery successfully removes the tumor, the cancer frequently comes back, a situation called recurrence. This means that ongoing monitoring and follow-up care are essential parts of managing the disease. Patients who have been treated for adrenocortical carcinoma typically need regular check-ups, imaging scans, and blood tests to watch for any signs that the cancer has returned.[1][13]

When the cancer spreads to distant organs—a process called metastasis—treatment becomes more challenging. Cancer that has metastasized to the lungs, liver, or bones is harder to control, and the focus of treatment often shifts from trying to cure the disease to managing symptoms and maintaining quality of life for as long as possible. In advanced cases, patients may face a median survival time of one to three years, though some individuals exceed these expectations with aggressive multimodal treatment approaches.[8][24]

How the Disease Progresses Without Treatment

Understanding what happens if adrenocortical carcinoma is left untreated helps explain why early detection and intervention are so critical. Without treatment, this cancer typically follows an aggressive course. The tumors can grow rapidly, sometimes reaching considerable size within a relatively short period. As they expand, they don’t just stay confined to the adrenal gland—they invade surrounding tissues and structures.[1]

The natural progression of untreated adrenocortical carcinoma involves several concerning developments. First, the tumor may grow large enough to press against nearby organs. The adrenal glands sit close to the kidneys, and as a tumor enlarges, it can compress the kidney, blood vessels, nerves, and other abdominal structures. This compression can cause persistent pain in the back or side, a feeling of fullness in the abdomen, and sometimes a visible or palpable lump that can be felt through the abdominal wall.[2][4]

Beyond local growth, the cancer’s ability to spread throughout the body poses the greatest threat. Adrenocortical carcinoma cells can break away from the original tumor and travel through the bloodstream or lymphatic system to establish new tumors in distant locations. The most common sites for metastasis include the lungs, liver, and bones, though the cancer can potentially spread to almost any part of the body. Once this widespread dissemination occurs, the body’s normal functions become increasingly compromised.[1][9]

For patients whose tumors produce hormones—which represents the majority of cases—the unchecked growth means escalating hormone levels with increasingly severe symptoms. Someone with a cortisol-producing tumor might experience progressive weight gain concentrated in the face, neck, and trunk, while their arms and legs become thinner. Their skin may become fragile and develop purple stretch marks. Blood pressure and blood sugar levels can climb dangerously high, leading to cardiovascular complications and diabetes. The excess cortisol can also weaken bones, making fractures more likely, and suppress the immune system, increasing vulnerability to infections.[2][4]

Tumors that overproduce aldosterone lead to progressively worsening high blood pressure that becomes difficult to control. The body loses potassium, causing muscle weakness, cramps, and potentially dangerous heart rhythm abnormalities. Patients may experience excessive thirst and urination as their body tries to manage the electrolyte imbalances. In severe cases, these metabolic derangements can lead to life-threatening complications.[2][14]

For women, tumors producing male sex hormones (androgens) cause progressive masculinization. Facial and body hair growth accelerates, menstrual periods stop, the voice deepens, and acne may worsen. Men with tumors producing female hormones (estrogen) may develop enlarged breasts and experience sexual dysfunction. These changes can be deeply distressing and significantly impact psychological well-being and quality of life.[2][4]

Potential Complications and Unexpected Developments

Adrenocortical carcinoma can lead to various complications, some arising from the cancer itself and others from the hormones it produces or the treatments required. Understanding these potential complications helps patients and families prepare for challenges that may arise during the disease course.

The most serious complication is metastatic spread. When cancer cells establish themselves in the lungs, breathing may become difficult. Coughing, shortness of breath, and chest pain can develop as tumors grow in lung tissue. Liver metastases can interfere with the liver’s ability to filter toxins from the blood, process nutrients, and produce proteins needed for blood clotting. This can lead to jaundice (yellowing of the skin and eyes), fluid accumulation in the abdomen, and bleeding problems. Bone metastases cause severe pain, increase the risk of fractures, and can interfere with bone marrow’s ability to produce blood cells, leading to anemia and increased infection risk.[1][9]

Hormone-related complications can be particularly troublesome. Excess cortisol production leads to Cushing syndrome, a condition that extends beyond cosmetic changes. The persistent elevation of cortisol weakens the immune system, making infections more frequent and harder to fight. It causes bones to lose density, increasing fracture risk significantly. Patients may develop diabetes or find that existing diabetes becomes much harder to control. The psychological effects of Cushing syndrome include mood swings, depression, anxiety, and sometimes severe psychiatric disturbances.[1][21]

High blood pressure resulting from excess aldosterone or cortisol can lead to cardiovascular complications. The heart must work harder to pump blood through constricted vessels, potentially leading to heart failure, stroke, or heart attack. Uncontrolled hypertension can also damage the kidneys, creating a cascade of problems including fluid retention and further blood pressure elevation.[2]

The dramatic shifts in sex hormones can cause complications beyond physical appearance changes. In women, the cessation of menstrual periods may lead to infertility. The emotional and psychological impact of virilization—developing male characteristics—can be profound, affecting self-image, relationships, and mental health. Similarly, men experiencing feminization may struggle with body image issues and the loss of sexual function.[2]

Even after successful surgery to remove the tumor, patients face specific risks. Because the tumor has been producing excess hormones, the remaining adrenal tissue (if only one gland was removed) or the patient’s pituitary gland may have been suppressed. This can lead to adrenal insufficiency, a condition where the body doesn’t produce enough cortisol and other essential hormones. Adrenal insufficiency can be life-threatening if not recognized and treated promptly. Patients typically require hormone replacement therapy to compensate for this deficiency.[15]

⚠️ Important
Patients who have had adrenal surgery or who are being treated with certain medications like mitotane must be aware of signs of adrenal crisis. This life-threatening condition can develop during times of stress, illness, or injury when the body cannot produce enough cortisol. Symptoms include severe weakness, confusion, abdominal pain, low blood pressure, and loss of consciousness. Anyone experiencing these symptoms needs immediate emergency medical care.

Treatment-related complications also deserve attention. Surgery to remove large tumors can be complex, potentially involving nearby organs if the cancer has invaded surrounding tissue. Surgical complications may include bleeding, infection, damage to nearby structures like the kidney or major blood vessels, and complications from anesthesia. Recovery can be lengthy, especially if the surgery was extensive.[16]

Chemotherapy, which is often used for advanced adrenocortical carcinoma, brings its own set of complications. The combination of drugs typically used—etoposide, doxorubicin, and cisplatin (EDP) along with mitotane—can cause significant side effects. These include nausea, vomiting, hair loss, fatigue, increased infection risk due to lowered white blood cell counts, anemia, and damage to organs like the kidneys and heart. Mitotane specifically can cause neurological side effects, digestive problems, and further suppression of adrenal function.[12][13]

Impact on Daily Life and Coping Strategies

Living with adrenocortical carcinoma affects virtually every aspect of daily life. The physical symptoms, emotional burden, treatment demands, and uncertainty about the future combine to create significant challenges for patients and their loved ones.

Physical limitations are often substantial. The fatigue associated with cancer and its treatment can be overwhelming. Simple activities that were once routine—preparing meals, doing laundry, going to work—may become exhausting. Patients often need to modify their daily schedules to include rest periods. Some find they can only accomplish a fraction of what they previously managed in a day. This reduction in capacity can be frustrating and may require accepting help from others, which can be difficult for people who value their independence.[24]

Pain is a common companion for many patients. Abdominal or back pain from the tumor, bone pain from metastases, or discomfort from surgical incisions can interfere with sleep, mobility, and overall comfort. Managing pain effectively often requires working closely with healthcare providers to find the right combination of medications and other pain relief strategies. Some patients benefit from physical therapy, gentle exercise, or complementary approaches like relaxation techniques.[24]

For patients with functioning tumors, the hormone-related symptoms create their own set of challenges. Weight gain, particularly in the face and trunk, can dramatically alter appearance and self-image. Clothing may no longer fit, and people may feel self-conscious about their changed appearance. Women dealing with excess facial and body hair may spend considerable time and emotional energy managing this unwanted growth. The combination of physical changes and feeling unwell can lead to social withdrawal, as patients may not feel comfortable in public or with friends.[2]

Work and career considerations present difficult decisions. Some patients need to reduce their work hours or stop working entirely, either because of physical limitations, frequent medical appointments, or the cognitive effects of treatment. This loss of professional identity can be painful, and the financial implications can add stress. Patients may need to navigate complex disability claims, insurance issues, and decisions about when or whether to inform employers and colleagues about their diagnosis.[24]

The treatment schedule itself becomes a major factor in daily life. Chemotherapy cycles, frequent blood tests to monitor hormone levels and medication effects, imaging scans every few months, and appointments with multiple specialists all require significant time and energy. Transportation to medical appointments can be challenging, especially for patients who feel too ill to drive. The financial burden of copays, parking fees, and time away from work adds up quickly.[13]

Emotional and psychological impacts are profound. Many patients experience anxiety about the future, fear of recurrence, and grief over losses—loss of health, independence, body image, fertility, and sometimes the loss of imagined futures. Depression is common and understandable given the circumstances. The uncertainty inherent in living with an aggressive cancer creates persistent stress. Patients may find themselves cycling through various emotional states: anger at the unfairness of the diagnosis, sadness about limitations, hope when treatment seems to be working, and fear when scan results are pending.[24]

Relationships with family and friends undergo changes. Loved ones may not know how to help or what to say. Some relationships deepen as people rally to provide support, while others may become strained. Partners may take on caregiving roles they never anticipated, which can shift relationship dynamics. Sexual relationships may be affected by physical symptoms, body image concerns, hormonal changes, and the simple exhaustion of coping with illness.[24]

Finding ways to cope with these challenges is essential for maintaining quality of life. Many patients benefit from connecting with mental health professionals who specialize in helping people with serious illness. Counselors and therapists can provide strategies for managing anxiety and depression, processing grief, and adapting to the changes cancer brings. Some patients find support groups helpful, whether in-person or online, as connecting with others who truly understand the experience can reduce feelings of isolation.[24]

Practical coping strategies include breaking tasks into smaller, manageable pieces; asking for and accepting help from others; prioritizing activities that bring joy or meaning; and being gentle with oneself about limitations. Some patients find that maintaining some elements of their pre-cancer routine helps them feel more normal, while others discover new interests or priorities that provide comfort and purpose.

Staying as physically active as possible, within the limits of individual capability, often helps with energy levels, mood, and overall well-being. Even gentle activities like short walks, stretching, or chair exercises can make a difference. Nutrition is also important, though appetites may be affected by illness and treatment. Working with a dietitian who understands cancer care can help patients find ways to maintain adequate nutrition even when eating is challenging.

Many patients find value in mindfulness practices, meditation, prayer, music, art, or time in nature. These activities can provide moments of peace and help manage stress. The key is finding what works for each individual, as coping strategies are deeply personal.

Supporting Family Members Through the Journey

When someone receives a diagnosis of adrenocortical carcinoma, the entire family is affected. Family members and close friends often want to help but may feel uncertain about how to provide meaningful support. Understanding what to expect and learning about available resources, including clinical trials, can help loved ones play an active and helpful role.

One of the most valuable things family members can do is educate themselves about adrenocortical carcinoma. Understanding the disease, its treatment options, and potential challenges helps family members provide informed support and participate meaningfully in medical discussions. Because this cancer is rare, even some healthcare providers may have limited experience with it, making it important for patients and families to advocate for care at specialized centers when possible.[5][13]

Clinical trials represent an important treatment option for adrenocortical carcinoma patients, especially given the limited number of approved therapies. Family members can play a crucial role in helping patients learn about and access clinical trials. Because this cancer is so uncommon, many advances in understanding and treatment come through research studies. Clinical trials may offer access to new therapies before they become widely available, and participating in research contributes to knowledge that may help future patients.[13][17]

Helping a loved one find relevant clinical trials requires some research. Several online databases list clinical trials for adrenocortical carcinoma. The National Cancer Institute’s website maintains a searchable database of trials, and cancer centers often have staff who help match patients with appropriate studies. When researching trials, family members should note the eligibility criteria, location of the study, what the trial involves, and who to contact for more information. Bringing this information to medical appointments allows the healthcare team to discuss whether a particular trial might be appropriate.[17]

Understanding what clinical trial participation involves helps set realistic expectations. Trials have specific inclusion and exclusion criteria that determine who can enroll. Some trials are only open to patients who haven’t yet received treatment, while others specifically recruit patients whose cancer has progressed despite standard therapy. Geographic location matters, as some trials require frequent visits to a specific research center. The trial protocol—the plan for the study—outlines what treatments will be given, what tests will be performed, and how often visits are required. Family members can help by organizing this information, helping coordinate transportation, and accompanying the patient to trial-related appointments.

Beyond clinical trials, family members can provide practical support in numerous ways. Accompanying the patient to medical appointments serves multiple purposes: it provides emotional support, ensures that someone else hears what doctors say (which is helpful because patients may miss information when they’re stressed or not feeling well), allows for two people to ask questions, and gives the accompanying person insight into what’s happening medically. Taking notes during appointments or recording them (with permission) helps preserve important information for later review.

Managing the logistical aspects of cancer care is substantial, and family members can help coordinate appointments, keep track of medication schedules, organize medical records, and communicate with various healthcare providers. Creating a system for tracking this information—whether through a notebook, computer file, or app—helps ensure nothing falls through the cracks. Keeping a list of all medications, including doses and schedules, is particularly important because patients with adrenocortical carcinoma often take multiple medications.

Transportation assistance is another practical way to help. Getting to appointments, especially when patients feel ill from treatment or symptoms, can be challenging. Family members who can provide rides or help arrange transportation through hospital programs or volunteer services remove a significant burden.

Help with daily tasks becomes increasingly important as illness and treatment progress. Preparing meals, grocery shopping, housework, yard work, childcare, and pet care are all areas where practical assistance makes a real difference. Rather than making vague offers to help “if you need anything,” specific offers tend to be more useful: “I’d like to bring dinner on Thursday; do you prefer chicken or pasta?” or “I’m free Saturday afternoon and would like to mow your lawn.”

Emotional support is equally important as practical help. Being present—sitting with the patient, listening without trying to fix everything, acknowledging how difficult the situation is—provides comfort. Family members should avoid minimizing concerns with statements like “stay positive” or “everything happens for a reason,” which can feel dismissive. Instead, validating feelings with responses like “this is so hard” or “I’m here with you” can be more supportive.

Family members should also be aware that patients may not always want to talk about cancer. Sometimes the best support is helping create moments of normalcy—watching a movie together, sharing a meal, talking about other topics, or engaging in activities the patient enjoys and can still manage. Following the patient’s lead about when to discuss the illness and when to focus on other things respects their autonomy and needs.

It’s important for family caregivers to recognize their own needs and limitations. Caring for someone with serious illness is demanding and can lead to caregiver burnout. Family members should make time for their own self-care, seek support for themselves (through counseling, support groups, or trusted friends), and accept that they can’t do everything. Setting boundaries and asking others for help is not selfish—it’s necessary for sustaining the ability to provide ongoing support.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Mitotane (Lysodren) – A chemotherapy drug that suppresses adrenal function and is used as adjuvant therapy after surgery and as treatment for metastatic disease. It is the only approved medication specifically for adrenocortical carcinoma.
  • Etoposide, Doxorubicin, and Cisplatin (EDP) – A combination chemotherapy regimen used with mitotane for metastatic adrenocortical carcinoma, considered the standard first-line treatment for advanced disease.
  • Ketoconazole – A drug that decreases production of cortisol, used to help manage symptoms of hormone excess in patients with functioning tumors.
  • Spironolactone (Aldactone) – A medication that blocks the effects of aldosterone, used to manage symptoms of excess aldosterone production.

Ongoing Clinical Trials on Adrenocortical carcinoma

  • Study on Cemiplimab and Mitotane for Patients with Advanced Adrenocortical Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Mitotane Alone or with Cisplatin and Etoposide for Patients with High-Risk Adrenocortical Carcinoma After Surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Sweden
  • Study on the Effectiveness of Adding Progesterone to Chemotherapy with Etoposide, Doxorubicin, Cisplatin, and Mitotane for Advanced Adrenocortical Carcinoma Patients

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Italy
  • Study of Pembrolizumab for Patients with Advanced Adrenocortical Carcinoma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

References

https://my.clevelandclinic.org/health/diseases/6152-adrenocortical-carcinoma

https://vicc.org/cancer-info/adult-adrenocortical-carcinoma

https://www.mayoclinic.org/diseases-conditions/adrenal-cancer/symptoms-causes/syc-20351026

https://www.cancer.gov/types/adrenocortical/patient/adrenocortical-treatment-pdq

https://www.ncbi.nlm.nih.gov/books/NBK278924/

https://www.cancerresearchuk.org/about-cancer/adrenal-gland-cancer/adrenal-cortical-cancer

https://www.dana-farber.org/cancer-care/types/adrenocortical-carcinoma

https://medlineplus.gov/ency/article/001663.htm

https://en.wikipedia.org/wiki/Adrenocortical_carcinoma

https://www.cancer.gov/types/adrenocortical/patient/adrenocortical-treatment-pdq

https://www.cancer.org/cancer/types/adrenal-cancer/treating/by-stage.html

https://amj.amegroups.org/article/view/5384/html

https://pmc.ncbi.nlm.nih.gov/articles/PMC4490795/

https://vicc.org/cancer-info/adult-adrenocortical-carcinoma

https://cancer.ca/en/cancer-information/cancer-types/adrenal-gland/treatment/adrenocortical-carcinoma-acc

https://www.mayoclinic.org/diseases-conditions/adrenal-cancer/diagnosis-treatment/drc-20446405

https://www.dana-farber.org/cancer-care/types/adrenocortical-carcinoma/treatment

https://www.cancer.org/cancer/types/adrenal-cancer/after-treatment/follow-up.html

https://www.mdanderson.org/cancerwise/stage-iv-adrenal-cancer-survivor–why-i-will-keep-climbing-mountains.h00-159619434.html

https://letscureacc.com/patient-guide-by-lets-cure-acc/

https://my.clevelandclinic.org/health/diseases/6152-adrenocortical-carcinoma

https://www.curetoday.com/view/adrenal-cancer-overview-and-treatment-guide

https://www.2minutemedicine.com/patient-basics-adrenocortical-carcinoma/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9739560/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What causes adrenocortical carcinoma?

The exact cause is unknown, but researchers have identified certain genetic mutations in tumor suppressor genes like TP53 and IGF2 that appear to drive this cancer. Some people develop it because they have inherited genetic conditions such as Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome, or Lynch syndrome that increase their risk. However, most cases occur in people without any known family history or genetic predisposition.

Can adrenocortical carcinoma be cured?

In some cases, particularly when the cancer is found early and confined to the adrenal gland, complete surgical removal can potentially cure the disease. However, the cancer frequently returns even after successful surgery. Patients diagnosed at advanced stages, when the cancer has already spread, face greater challenges, and treatment focuses on controlling the disease and managing symptoms rather than achieving cure.

Why does adrenocortical carcinoma cause so many different symptoms?

The variety of symptoms depends on which hormones the tumor produces. Most adrenocortical carcinomas are “functioning” tumors that release excessive amounts of hormones like cortisol, aldosterone, testosterone, or estrogen. Each hormone causes different effects: cortisol excess leads to weight gain and high blood pressure, aldosterone causes high blood pressure and muscle weakness, and sex hormones cause changes in physical characteristics. Non-functioning tumors may cause no symptoms until they grow large enough to press on nearby organs.

How often do I need follow-up appointments after treatment?

Follow-up care is extensive because adrenocortical carcinoma often recurs. Patients typically need regular monitoring that includes physical examinations, blood tests to measure hormone levels, and imaging scans (such as CT or MRI) every few months initially, then at gradually increasing intervals if no recurrence is detected. The exact schedule depends on individual circumstances and risk factors, but lifelong surveillance is usually necessary.

Will I need hormone replacement after adrenal surgery?

It depends on your specific situation. If only one adrenal gland is removed and the other one is healthy and functioning, you may not need hormone replacement. However, if both adrenal glands are removed or if your remaining adrenal tissue has been suppressed by the tumor’s hormone production, you will need lifelong hormone replacement therapy. Additionally, patients taking mitotane often require hormone replacement because this medication suppresses adrenal function.

🎯 Key takeaways

  • Adrenocortical carcinoma affects only about 1 in 1 million people annually, making it an exceptionally rare cancer that many doctors may never encounter in their careers.
  • About 70% of patients are diagnosed at advanced stages (III or IV) because early-stage tumors often cause no symptoms, highlighting the importance of investigating any unusual abdominal findings.
  • Five-year survival ranges dramatically from 82% for stage I disease to just 13% for stage IV, underscoring how critical early detection is for improving outcomes.
  • Most tumors are “functioning,” meaning they produce excess hormones that cause symptoms like rapid weight gain, high blood pressure, excess body hair, or irregular periods—symptoms that can initially be mistaken for other conditions.
  • The cancer frequently recurs even after successful surgery, making long-term monitoring essential for all patients regardless of initial treatment success.
  • Mitotane is the only medication specifically approved for adrenocortical carcinoma and has been used since 1960, often combined with chemotherapy for advanced disease.
  • Having certain inherited genetic conditions like Li-Fraumeni syndrome or Beckwith-Wiedemann syndrome significantly increases the risk of developing this cancer.
  • Clinical trials offer important options for patients with this rare cancer, providing access to new treatments and contributing to research that may help future patients facing this diagnosis.